Novo acquires respiratory products supplier Innocath


novo-innocathNovo Klinik-Service (Bergheim, Germany), a portfolio company of SHS, recently announced that it has acquired Innocath (Duisburg, Germany). The fiancial details of the deal were not disclosed.

With the acquisition, Novo is adding Innocath’s ventilated patient care products to its product line of airway management. Some of Innocath’s products include respiratory tubing systems, tubes, laryngeal masks and accessories for tracheostomy patients.

“The partnership with Novo will open up further growth opportunities for us as our product ranges perfectly complement each other. This creates cross-selling potential on both sides and helps us further strengthen the effectiveness of our sales activities. Our aim is to be in a position to offer our products throughout Germany and increasingly internationally as well,” said Bernhard Behme, founder of Innocath.

Novo has been a manufacturer of medical aids and medical technology solutions for intensive care medicine, anesthesia and nursing for more than 30 years. It specializes in airway management, infusion and surgical drain management and fixation and pressure relief management.

“Innocath stands for high-quality products and excellent customer service,” said Udo Lutz, managing director of Novo. “We will be building on these strengths and placing particular emphasis on jointing expanding Innocath’s sales activities.”

Inside Hologic's evolving definition of women's healthcare

textadimage Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.

At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!


Use code WOMENSHEALTH to save an additional 10%.

Speak Your Mind